Title:
【発明の名称】GM―CSFを用いる白血球機能障害の治療
Document Type and Number:
Japanese Patent JPH03504980
Kind Code:
A
Abstract:
A method of treating leukocyte dysfunction in a mammal, preferably a human, wherein said dysfunction is associated with physical trauma, is disclosed. Preferably the method is used wherein the dysfunction is associated with thermal injury. The method comprises administering to the mammal an effective amount of GM-CSF to potentiate the function of the dysfunctional leukocytes. The use of GM-CSF for the manufacture of a medicament for use in treating a patient having such leukocyte dysfunction and a pharmaceutical composition comprising GM-CSF for use in such treating are also disclosed.
More Like This:
| JPS6466127 | ANTITUMOR AGENT |
| WO/2002/055694 | DISCRIMINATIVE NUCLEIC ACID ANALYSIS USING CLONE SEQUENCE SIGNATURES |
| JP2003516760 | [Title of Invention] Regulation of protein kinase |
Inventors:
Bonnen, Eric M
Application Number:
JP50325390A
Publication Date:
October 31, 1991
Filing Date:
January 26, 1990
Export Citation:
Assignee:
SCHERING CORPORATION
International Classes:
A61K38/00; A61K38/18; A61K38/19; A61P7/00; A61P9/00; A61P37/00; (IPC1-7): A61K37/02
Attorney, Agent or Firm:
Kyozo Yuasa (6 people outside)